Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion

被引：0
|
作者：
Bacharier, L. B. [1 ]
Maspero, J. F. [2 ]
Katelaris, C. H. [3 ]
Fiocchi, A. G. [4 ]
Gagnon, R. [5 ]
de Mir, I. [6 ]
Guilbert, T. W. [7 ,8 ]
Jackson, D. J. [9 ]
Li, N. [10 ]
Akinlade, B. [11 ]
Laws, E. [10 ]
Mannent, L. P. [12 ]
Maloney, J. [11 ]
Tawo, K. [10 ]
Khokhar, F. A. [11 ]
Hardin, M. [13 ]
Abdulai, R. M. [13 ]
Lederer, D. J. [11 ]
Robinson, L. B. [13 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Pediat, Nashville, TN USA
[2] Fdn CIDEA, Buenos Aires, DF, Argentina
[3] Campbelltown Hosp, Campbelltown, NSW, Australia
[4] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy
[5] Clin Specialisee Allergie Capitale, Quebec City, PQ, Canada
[6] Hosp Univ Maternoinfantil Vall dHebron, Barcelona, Spain
[7] Cincinnati Childrens Hosp, Cincinnati, OH USA
[8] Univ Cincinnati, Cincinnati, OH USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[10] Sanofi, Bridgewater, NJ USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Chilly Mazarin, France
[13] Sanofi, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5988
引用
收藏
页数：2
相关论文
共 50 条
  • [21] LONG-TERM EFFICACY OF DUPILUMAB: 3-YEAR DATA OF QUEST PATIENTS WITH MODERATE-TO-SEVERE ASTHMA ENROLLED IN LIBERTY ASTHMA TRAVERSE
    Pavord, I. D.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Domingo, C.
    Wechsler, M. E.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Mannent, L.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M.
    THORAX, 2021, 76 : A53 - A54
  • [22] Impact of Early Transient Increase in Eosinophil Count on the Long-term Efficacy of Dupilumab in Patients With Moderate-to-Severe Asthma: Liberty Asthma Traverse
    Lugogo, N. L.
    Pavord, I. D.
    Castro, M.
    Papi, A.
    Bourdin, A.
    Wechsler, M. E.
    Cote, A.
    Xia, C.
    Soliman, M.
    Pandit-Abid, N.
    Jacob-Nara, J. A.
    Sacks, H. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [23] DUPILUMAB REDUCED EXACERBATIONS AND IMPROVED LUNG FUNCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA AND PRIOR EXACERBATIONS: LIBERTY ASTHMA TRAVERSE STUDY
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    CHEST, 2022, 162 (04) : 1936A - 1938A
  • [24] Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma
    Papi, Alberto
    Castro, Mario
    Corren, Jonathan
    Pavord, Ian D.
    Tohda, Yuji
    Altincatal, Arman
    Pandit-Abid, Nami
    Laws, Elizabeth
    Akinlade, Bolanle
    Mannent, Leda P.
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    RESPIRATORY MEDICINE, 2024, 224
  • [25] Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
    Castro, Mario
    Rabe, Klaus F.
    Corren, Jonathan
    Pavord, Ian D.
    Katelaris, Constance H.
    Tohda, Yuji
    Zhang, Bingzhi
    Rice, Megan S.
    Maroni, Jaman
    Rowe, Paul
    Pirozzi, Gianluca
    Amin, Nikhil
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil M. H.
    Teper, Ariel
    ERJ OPEN RESEARCH, 2020, 6 (01)
  • [26] Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma
    Phipatanakul, W.
    Prenzel, F.
    Papadopoulos, N. G.
    Bacharier, L. B.
    Hamelmann, E.
    Fiocchi, A. G.
    Altincatal, A.
    Gall, R.
    Ledanois, O.
    KLINISCHE PADIATRIE, 2024, 236 (02): : S3 - S4
  • [27] Long-Term Dupilumab Treatment Effect On Safety And Clinical Efficacy In Children With Type 2 Asthma: LIBERTY ASTHMA EXCURSION
    Bacharier, Leonard
    Maspero, Jorge
    Katelaris, Constance
    Fiocchi, Alessandro
    Gagnon, Remi
    de Mir, Ines
    Guilbert, Theresa
    Jackson, Daniel
    Li, Ning
    Akinlade, Bolanle
    Laws, Elizabeth
    Mannent, Leda
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal
    Hardin, Megan
    Abdulai, Raolat
    Lederer, David
    Robinson, Lacey
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB15 - AB15
  • [28] Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
    Maspero, Jorge F.
    Peters, Anju T.
    Chapman, Kenneth R.
    Domingo, Christian
    Stewart, John
    Hardin, Megan
    Maroni, Jaman
    Tawo, Kelsey
    Khokhar, Faisal A.
    Mortensen, Eric
    Laws, Elizabeth
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (04): : 991 - 997.e6
  • [29] DUPILUMAB IN MODERATE-TO-SEVERE ASTHMA: GOOD OUTCOMES IN CHILDREN
    Nuttall, Amy G.
    THORAX, 2022, 77 (04) : 424 - 424
  • [30] Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
    Gomez, Lucia De Prado
    Pavord, Ian
    Busse, William
    Brightling, Christopher E.
    Wechsler, Michael E.
    Rabe, Klaus F.
    Zhang, Mei
    Xing, Jun
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    ERJ OPEN RESEARCH, 2023, 9 (02)
12345